Phase I Dose-Escalation Results for Marizomib in Newly Diagnosed GlioblastomaByDaniela Bota, MDJune 28th 2018Daniela A. Bota, MD, medical director of Neuro-Oncology at University of California Irvine, discusses the findings from a dose-escalation trial of marizomib.